[Click eStock] "Humedics Expands Filler Export Regions"

Yuanta Securities analyzed on the 4th that Humedics is expected to grow due to increased filler exports and the localization of heparin sodium.

Son Hyun-jung, a researcher at Yuanta Securities, explained, "From the second half of this year, we will expand filler exports to Russia, Southeast Asia, and the Middle East," adding, "We plan to accelerate overseas growth."

He continued, "In the Brazilian market, we aim to obtain approval for body filler products within this year," and added, "This high-profit product will contribute to improving operating profit."

He predicted, "The next-generation composite filler 'Belpien' under development is an innovative skin booster that combines the volumizing effect of HA with the skin regeneration effect of PN," and said, "It will strengthen competitiveness in the market."

Researcher Son also analyzed, "In March, we succeeded in localizing the heparin sodium raw material for the first time in Korea," and said, "From the second half of this year, a mass production system will be established, and some sales will be recognized." He emphasized, "Currently, the majority of heparin sodium raw materials worldwide are supplied from China," and added, "The United States is trying to reduce dependence on Chinese products through regulations such as the Biosecurity Act."

It is estimated to achieve sales of 181.4 billion KRW and operating profit of 50 billion KRW this year, which are increases of 19.1% and 34.0%, respectively, compared to last year.

This content was produced with the assistance of AI translation services.